Dynatronics (NASDAQ:DYNT) Coverage Initiated at StockNews.com

Stock analysts at StockNews.com began coverage on shares of Dynatronics (NASDAQ:DYNT – Get Rating) in a research report issued on Tuesday. The brokerage set a “hold” rating on the medical equipment provider’s stock.

Dynatronics Stock Performance

DYNT stock opened at $0.42 on Tuesday. The firm has a market cap of $8.00 million, a price-to-earnings ratio of -1.32 and a beta of 0.26. The firm has a 50-day simple moving average of $0.44 and a two-hundred day simple moving average of $0.52. Dynatronics has a one year low of $0.30 and a one year high of $0.91. The company has a debt-to-equity ratio of 0.14, a quick ratio of 0.73 and a current ratio of 1.90.

Dynatronics (NASDAQ:DYNT – Get Rating) last released its quarterly earnings results on Thursday, November 10th. The medical equipment provider reported ($0.04) EPS for the quarter, beating the consensus estimate of ($0.06) by $0.02. The business had revenue of $12.05 million during the quarter, compared to analyst estimates of $11.81 million. Dynatronics had a negative net margin of 11.30% and a negative return on equity of 33.81%. On average, equities analysts forecast that Dynatronics will post -0.12 EPS for the current fiscal year.

Dynatronics Company Profile

(Get Rating)

Dynatronics Corporation, a medical device company, designs, manufactures, and sells physical therapy, rehabilitation, orthopedics, pain management, and athletic training products in the United States. The company offers orthopedic soft bracing products include cervical collars, shoulder immobilizers, arm slings, wrist and elbow supports, abdominal and lumbosacral supports, maternity supports, knee immobilizers and supports, ankle walkers and supports, plantar fasciitis splints, and cold therapy products; and therapeutic modality devices comprising electrotherapy, ultrasound, phototherapy, traction, hot and cold therapy, and electrodes.